Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility

The molecular signaling mechanisms between glomerular cell types during initiation/progression of diabetic kidney disease (DKD) remain poorly understood. We compared the early transcriptome profile between DKD-resistant C57BL/6J and DKD-susceptible DBA/2J (D2) glomeruli and demonstrated a significant downregulation of essential mitochondrial genes in glomeruli from diabetic D2 mice, but not in C57BL/6J, with comparable hyperglycemia. Diabetic D2 mice manifested increased mitochondrial DNA lesions (8-oxoguanine) exclusively localized to glomerular endothelial cells after 3 weeks of diabetes, and these accumulated over time in addition to increased urine secretion of 8-oxo-deoxyguanosine. Detailed assessment of glomerular capillaries from diabetic D2 mice demonstrated early signs of endothelial injury and loss of fenestrae. Glomerular endothelial mitochondrial dysfunction was associated with increased glomerular endothelin-1 receptor type A (Ednra) expression and increased circulating endothelin-1 (Edn1). Selective Ednra blockade or mitochondrial-targeted reactive oxygen species scavenging prevented mitochondrial oxidative stress of endothelial cells and ameliorated diabetes-induced endothelial injury, podocyte loss, albuminuria, and glomerulosclerosis. In human DKD, increased urine 8-oxo-deoxyguanosine was associated with rapid DKD progression, and biopsies from patients with DKD showed increased mitochondrial DNA damage associated with glomerular endothelial EDNRA expression. Our studies show that DKD susceptibility was linked to mitochondrial dysfunction, mediated largely by Edn1–Ednra in glomerular endothelial cells representing an early event in DKD progression, and suggest that cross talk between glomerular endothelial injury and podocytes leads to defects and depletion, albuminuria, and glomerulosclerosis.

[1]  P. Groop,et al.  Incidence of end-stage renal disease in patients with type 1 diabetes. , 2005, Journal of the American Medical Association (JAMA).

[2]  C. Dessy,et al.  Hyaluronidase 1 Deficiency Preserves Endothelial Function and Glycocalyx Integrity in Early Streptozotocin-Induced Diabetes , 2016, Diabetes.

[3]  T. Rabelink,et al.  Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx. , 2016, Journal of the American Society of Nephrology : JASN.

[4]  A. Koster,et al.  Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy , 2016, Diabetes.

[5]  E. Bottinger,et al.  TGFβ-Induced Actin Cytoskeleton Rearrangement in Podocytes Is Associated with Compensatory Adaptation of Mitochondrial Energy Metabolism , 2015, Nephron.

[6]  J. He,et al.  Reduced Krüppel-like Factor 2 expression may aggravate the endothelial injury of diabetic nephropathy , 2014, Kidney international.

[7]  E. Araki,et al.  Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy , 2014, Journal of diabetes investigation.

[8]  H. Parving,et al.  The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.

[9]  D. Webb,et al.  Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis. , 2014, Journal of the American Society of Nephrology : JASN.

[10]  V. D’Agati,et al.  Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. , 2014, The Journal of clinical investigation.

[11]  J. McMurray,et al.  Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. , 2013, The New England journal of medicine.

[12]  B. Viollet,et al.  AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. , 2013, The Journal of clinical investigation.

[13]  H. Szeto,et al.  The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. , 2013, Journal of the American Society of Nephrology : JASN.

[14]  M. Murphy,et al.  Mitochondrially targeted compounds and their impact on cellular bioenergetics☆ , 2013, Redox biology.

[15]  John F. Bertram,et al.  Glomerular Endothelial Cell Injury and Damage Precedes That of Podocytes in Adriamycin-Induced Nephropathy , 2013, PloS one.

[16]  Yuichiro Yamada,et al.  SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic mice. , 2012, Metabolism: clinical and experimental.

[17]  K. Connelly,et al.  eNOS deficiency predisposes podocytes to injury in diabetes. , 2012, Journal of the American Society of Nephrology : JASN.

[18]  B. Coll,et al.  Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD). , 2012, Life sciences.

[19]  R. Nelson,et al.  Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy , 2012, Kidney international.

[20]  B. Haraldsson,et al.  The glomerular endothelium: new insights on function and structure , 2012, Current opinion in nephrology and hypertension.

[21]  P. Karran,et al.  6‐Thioguanine damages mitochondrial DNA and causes mitochondrial dysfunction in human cells , 2011, FEBS letters.

[22]  Y. Uchijima,et al.  Identification and developmental analysis of endothelin receptor type-A expressing cells in the mouse kidney. , 2011, Gene expression patterns : GEP.

[23]  A. Fogo,et al.  The glomerulus--a view from the inside--the endothelial cell. , 2010, The international journal of biochemistry & cell biology.

[24]  S. Chakrabarti,et al.  Glucose-induced endothelin-1 expression is regulated by ERK5 in the endothelial cells and retina of diabetic rats. , 2010, Canadian journal of physiology and pharmacology.

[25]  V. Darley-Usmar,et al.  Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen species. , 2010, Free radical biology & medicine.

[26]  C. Alpers,et al.  Mouse models of diabetic nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.

[27]  M. Ohno,et al.  Construction and characterization of a cell line deficient in repair of mitochondrial, but not nuclear, oxidative DNA damage. , 2009, Methods in molecular biology.

[28]  M. Ohno,et al.  Quantitative analysis of oxidized guanine, 8-oxoguanine, in mitochondrial DNA by immunofluorescence method. , 2009, Methods in molecular biology.

[29]  Matthias Merkenschlager,et al.  Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. , 2008, Journal of the American Society of Nephrology : JASN.

[30]  M. Cooper,et al.  Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes , 2008, Diabetes.

[31]  H. Parving,et al.  Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years , 2008, Diabetes Care.

[32]  J. Trnka,et al.  A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria. , 2008, Free radical biology & medicine.

[33]  Jenny Nyström,et al.  Properties of the Glomerular Barrier and Mechanisms of Proteinuria , 2022 .

[34]  S. Satchell,et al.  What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? , 2008, Diabetologia.

[35]  M. Caramori,et al.  Podocyte Detachment and Reduced Glomerular Capillary Endothelial Fenestration in Human Type 1 Diabetic Nephropathy , 2007, Diabetes.

[36]  B. Ballermann Contribution of the Endothelium to the Glomerular Permselectivity Barrier in Health and Disease , 2007, Nephron Physiology.

[37]  H. Parving,et al.  Irbesartan Treatment Reduces Biomarkers of Inflammatory Activity in Patients With Type 2 Diabetes and Microalbuminuria , 2006, Diabetes.

[38]  R. Harris,et al.  Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. , 2006, Journal of the American Society of Nephrology : JASN.

[39]  C. Palmeira,et al.  Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. , 2006, Toxicology and applied pharmacology.

[40]  T. Kern,et al.  Association between endothelin-1 and collagen deposition in db/db diabetic mouse kidneys. , 2006, Biochemical and biophysical research communications.

[41]  T. Meyer,et al.  Impact of genetic background on nephropathy in diabetic mice. , 2006, American journal of physiology. Renal physiology.

[42]  M. Schiffer,et al.  Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. , 2006, Diabetes.

[43]  Jianping Jin,et al.  Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. , 2005, Diabetes.

[44]  E. Ritz,et al.  Nephron number and renal risk in hypertension and diabetes. , 2005, Journal of the American Society of Nephrology : JASN.

[45]  Haifeng Guo,et al.  Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  K. Takahashi,et al.  Elevated plasma endothelin in patients with diabetes mellitus , 1990, Diabetologia.

[47]  K. Sharma,et al.  Genomic strategies for diabetic nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.

[48]  Li-jun Ma,et al.  Model of robust induction of glomerulosclerosis in mice: importance of genetic background. , 2003, Kidney international.

[49]  S. Yusuf,et al.  Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. , 2002, Diabetes care.

[50]  M. Brownlee Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[51]  T. Lüscher,et al.  Endothelins and Endothelin Receptor Antagonists: Therapeutic Considerations for a Novel Class of Cardiovascular Drugs , 2000, Circulation.

[52]  J. Rosenblatt,et al.  Analysis of gene-specific DNA damage and repair using quantitative polymerase chain reaction. , 2000, Methods.

[53]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[54]  R. G. Nelson,et al.  Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria , 1999, Diabetologia.

[55]  Y. Hinokio,et al.  Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. , 1999, Diabetes research and clinical practice.

[56]  H. Schägger,et al.  Altered gene expression and functions of mitochondria in human nephrotic syndrome , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  H. Rüdiger,et al.  Assay for the determination of urinary 8-hydroxy-2'-deoxyguanosine by high-performance liquid chromatography with electrochemical detection. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[58]  Y. Hirata,et al.  A novel ETA antagonist (BQ‐123) inhibits endothelin‐1‐induced phosphoinositide breakdown and DNA synthesis in rat vascular smooth muscle cells , 1992, FEBS letters.

[59]  L. Oberley Free radicals and diabetes. , 1988, Free radical biology & medicine.